Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance

M Rebucci, P Peixoto, A Dewitte… - International …, 2011 - spandidos-publications.com
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …
被引用次数：124 相关文章

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance

M Rebucci, P Peixoto, A Dewitte… - … journal of oncology, 2011 - pubmed.ncbi.nlm.nih.gov
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …

[引用][C] Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

M Rebucci, P Peixoto, A Dewitte, N Wattez… - 2011 - agris.fao.org
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT
inhibition in bypassing this resistance. | International Journal of Oncology Food and …

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance

D Nuncques - International Journal of Oncology, 2011 - ingentaconnect.com
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance

M Rebucci, P Peixoto, A Dewitte… - International …, 2011 - spandidos-publications.com
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

M Rebucci, P Peixoto, A Dewitte, N Wattez… - International Journal of …, 2011 - orbi.uliege.be
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …

[引用][C] Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance

M REBUCCI - Int J Oncol, 2011 - cir.nii.ac.jp

[引用][C] Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance

M REBUCCI, P PEIXOTO, E LARTIGAU… - … journal of oncology, 2011 - pascal-francis.inist.fr
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT
inhibition in bypassing this resistance CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF] researchgate.net

[PDF][PDF] Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance

M REBUCCI, P PEIXOTO, A DEWITTE… - INTERNATIONAL …, 2011 - researchgate.net
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

M Rebucci, P Peixoto, A Dewitte, N Wattez… - … Journal of Oncology, 2011 - europepmc.org
EGFR is frequently overexpressed in head and neck squamous cell cancer (HNSCC).
Cetuximab is a monoclonal antibody designed to interact with EGFR, block its activation …